Feng-lan Chiu

TPQ 11529, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Zika virus impairs non-homologous end joining and exacerbates DNA damage in neural progenitors derived from Huntington's disease iPSCs via mutant huntingtin-elicited Ku70/Ku80 complex disruption.

Zika virus impairs non-homologous end joining and exacerbates DNA damage in neural progenitors derived from Huntington's disease iPSCs via mutant huntingtin-elicited Ku70/Ku80 complex disruption.

Journal: Stem cell research & therapy

Published: April 05, 2025

Author Correction: Amyloid modifier SERF1a interacts with polyQ-expanded huntingtin-exon 1 via helical interactions and exacerbates polyQ-induced toxicity.

Author Correction: Amyloid modifier SERF1a interacts with polyQ-expanded huntingtin-exon 1 via helical interactions and exacerbates polyQ-induced toxicity.

Journal: Communications biology

Published: May 18, 2024

Author Correction: Amyloid modifier SERF1a interacts with polyQ-expanded huntingtin-exon 1 via helical interactions and exacerbates polyQ-induced toxicity.

Author Correction: Amyloid modifier SERF1a interacts with polyQ-expanded huntingtin-exon 1 via helical interactions and exacerbates polyQ-induced toxicity.

Journal: Communications biology

Published: October 09, 2023

Amyloid modifier SERF1a interacts with polyQ-expanded huntingtin-exon 1 via helical interactions and exacerbates polyQ-induced toxicity.

Amyloid modifier SERF1a interacts with polyQ-expanded huntingtin-exon 1 via helical interactions and exacerbates polyQ-induced toxicity.

Journal: Communications biology

Published: January 05, 2023

Galectin-3 aggravates microglial activation and tau transmission in tauopathy.

Galectin-3 aggravates microglial activation and tau transmission in tauopathy.

Journal: The Journal of clinical investigation

Published: September 19, 2022

TRAX Provides Neuroprotection for Huntington's Disease Via Modulating a Novel Subset of MicroRNAs.

TRAX Provides Neuroprotection for Huntington's Disease Via Modulating a Novel Subset of MicroRNAs.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: February 20, 2022

Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.

Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.

Journal: Open biology

Published: April 09, 2019

Inhibition of Japanese encephalitis virus infection by the host zinc-finger antiviral protein.

Inhibition of Japanese encephalitis virus infection by the host zinc-finger antiviral protein.

Journal: PLoS pathogens

Published: March 19, 2018

GSK3β negatively regulates TRAX, a scaffold protein implicated in mental disorders, for NHEJ-mediated DNA repair in neurons.

GSK3β negatively regulates TRAX, a scaffold protein implicated in mental disorders, for NHEJ-mediated DNA repair in neurons.

Journal: Molecular psychiatry

Published: May 11, 2017

Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs.

Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs.

Journal: Human molecular genetics

Published: May 12, 2015

Aberrant astrocytes impair vascular reactivity in Huntington disease.

Aberrant astrocytes impair vascular reactivity in Huntington disease.

Journal: Annals of neurology

Published: December 16, 2014

Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease.

Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease.

Journal: Human molecular genetics

Published: April 05, 2014

Showing 1-12 of 13

Last Updated: 09/26/2026